Health

---

Argento led their first major external round and secured committed value-based sector investors for the long term. Simultaneously we helped improve their product, tech platform, sales and market approach securing first major brand customers at scale – current valuation $2.4 billion.  

Developed the Business plan, Financials, Go-to-market and agreed initial Seed to help secure client's first major customer acquisition - with a follow-up $9M funding agreed based on achieving targets over 2-3 years. 

Argento led the Pre-Seed and Seed rounds with long-term trusted smart investors. Re-positioned the market approach to high value but under served market segments and helped close initial Pharma deals, whilst boosting their industry profile – current valuation $270 million. 

Invested into forming a new JV with South America’s leading Health Data provider and developed their sales, marketing and delivery systems to fulfill large-scale customer requirements across the region. Argento is deepening its commitment to long-term healthcare solutions for all. 

Argento is an early-stage investor in this innovate new smart materials start-up which is aiming to become a market leader in Sports, Gaming and Health Therapeutics segments as they gain well-known brand partners – current valuation $110 million

Secured a major Term Sheet for a MedTech startup - after modifying their go-to-market and product development strategies - to improve their product, develop AI capabilities and facilitate their a rapidly growing order book.

Reworked their original product / market approach, then developed and tested an global business plan and lead their go-to-market – which validated their product-market fit. We led the first external investment, securing $2 million Seed funding within 3 months. 

We launched a Healthcare start-up, executed its go-to-market and partnered with several sector leading medical distributors which gave the client early national reach leading to rapid sales expansion and sustained profitability. 

Pivoted client to much larger, fast growing market segments, developed a strong market message and closed number of key industry reference sales – leading to a competitor takeover bid.  

Argento led in their first external Seed round and worked intensively gaining nationwide sales distribution partners and client sales almost from the outset, from leading Health & Wellness, Medical, Govt, Insurers and Employers across the US.

Evaluated their investment proposition and created a compelling investor case that led to their first Seed and Series A investments. Attracted notable BioTech funds to support their research and cultivated future Pharma sales